Don't get left behind! The modernized ClinicalTrials.gov is coming. Check it out now.
Say goodbye to ClinicalTrials.gov!
The new site is coming soon - go to the modernized ClinicalTrials.gov
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00256152
Recruitment Status : Completed
First Posted : November 21, 2005
Last Update Posted : February 4, 2019
Sponsor:
Collaborator:
Population Health Research Institute
Information provided by (Responsible Party):
Abbott Medical Devices

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:

In patients with a standard indication for pacing and no previous history of AF, detection of Atrial High Rate Episodes predicts an increased risk of stroke and systemic embolism.

Overdrive atrial pacing with the AF Suppression algorithm will reduce the risk of symptomatic AF in patients with standard indication for pacing and no previous history of AF.


Condition or disease Intervention/treatment Phase
Hypertension Atrial Fibrillation Device: AF Suppression Pacing Algorithm Phase 4

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 2580 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial
Study Start Date : September 2004
Actual Primary Completion Date : June 2010
Actual Study Completion Date : June 2010

Resource links provided by the National Library of Medicine


Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
No Intervention: AF Suppression OFF
Experimental: AF Suppression ON Device: AF Suppression Pacing Algorithm


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Composite of ischemic stroke & Non-CNS systemic embolism [ Time Frame: 3 years ]
  2. Symptomatic or Asymptomatic AT documented by ECG [ Time Frame: 3 years ]

Secondary Outcome Measures :
  1. Myocardial infarction [MI], Vascular death Composite of stroke, MI or vascular death [ Time Frame: 3 years ]

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   65 Years and older   (Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria

  1. Age ≥ 65 years
  2. History of hypertension requiring pharmacological therapy (≥ 4 weeks of therapy).
  3. Recent (< 8 weeks) St. Jude Medical Inc. pacemaker implant (IDENTITY® Adx DR (Model 5386/5380)), ICD implant (EPIC 2 or Atlas 2) or other St. Jude Medical Inc. pacemaker or ICD with the same capabilities.
  4. In pacemaker patients only the primary indication for pacing is sinus or AV node disease.

Exclusion Criteria

  1. Previous documented AF, atrial flutter (lasting greater than 5 minutes), or other sustained SVT (not including episodes detected by the device)
  2. Geographic/social or psychiatric factor likely to interfere with follow-up
  3. Requirement for oral anticoagulation (heart valve, deep vein thrombosis, etc.)
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00256152


Locations
Layout table for location information
Canada, Ontario
McMaster University
Hamilton, Ontario, Canada
Sponsors and Collaborators
Abbott Medical Devices
Population Health Research Institute
Investigators
Layout table for investigator information
Study Chair: Stuart Connolly, MD McMaster University
Study Chair: Stephan Hohnloser, MD Goethe University
Principal Investigator: Carlos Morillo, MD McMaster University
Principal Investigator: Jeff Healey, MD McMaster University
Principal Investigator: Carsten Israel, MD Goethe University
Principal Investigator: Michael Gold, MD Medical University of South Carolina
Principal Investigator: Chu-Pak Lau, MD The University of Hong Kong
Principal Investigator: Alessandro Capucci, MD Ospedale Clinic, Piacenza Italy
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Layout table for additonal information
Responsible Party: Abbott Medical Devices
ClinicalTrials.gov Identifier: NCT00256152    
Other Study ID Numbers: CRD291
First Posted: November 21, 2005    Key Record Dates
Last Update Posted: February 4, 2019
Last Verified: February 2019
Keywords provided by Abbott Medical Devices:
Atrial fibrillation
Pacemaker
AF suppression pacing
Indications for Pacemaker Implantation due to sinus node or atrio-ventricular node disease
Additional relevant MeSH terms:
Layout table for MeSH terms
Atrial Fibrillation
Cardiovascular Diseases
Arrhythmias, Cardiac
Heart Diseases
Pathologic Processes